Sort by
Refine Your Search
-
Listed
-
Field
-
Scheduled Hours 40 Position Summary Offering a 4-day-10 hour schedule option as well as a bonus incentive program, Washington University Department of Otolaryngology (Ear, Nose, and Throat
-
-person proctored credentials from other certifying bodies may be accepted upon approval from Human Resources. Substitutions include: Graduate of an accredited nursing program (such as RN/LPN
-
opportunity to hire a PROGRAM COORDINATOR / UW MEDICINE PATIENT SCHEDULER. WORK SCHEDULE: Full-Time, Day Shift Mondays - Fridays, 8:00 am - 5:00 pm DEPARTMENT DESCRIPTION: As the only lung transplant program in
-
to counteract opioid use disorders and overdoses. Our unique multidisciplinary research program integrates vaccine design, antibody engineering, immunomodulators and adjuvants, formulation and delivery platforms
-
, Social Work, Social Sciences, Life Sciences, Business, Communications, or related fields • At least three years of experience in program operations, project management, or in managing and/or recruiting
-
their families by providing oversight of the PAVE program, support the initiatives of Student Affairs and connect with campus partners. With an increasing population of military connected college students
-
with the department’s informatics and analytics team to advance revenue cycle capabilities. Utilize Medical School and national resources to benchmark and innovate billing processes. Represent
-
(FISH). Position includes opportunity for advancement to Technologist I and further. Hands-on training includes recognition and classification of G-banded chromosomes using microscopes and computer
-
regulations and report any accidents or injuries immediately. • Maintain route schedule. • Drive various vehicles & routes and work varied shifts as mandated by program need. • Provide excellent customer
-
the Department of Medicine. The Foltz lab works at the intersection of translational immunology and computational biology. We study mechanisms of response and resistance to natural killer (NK) cell therapies